With the expiration of the Canadian patents for weight-loss drugs Ozempic and Wegovy in January, experts are looking to mid-summer for cheaper generic replacements to come on the market. The patents kept the cost of those drugs high because Danish drug manufacturer Novo Nordisk was the only company that could make them. Health Canada says it is reviewing nine submissions for generic versions of the popular weight loss medications. Advertisement AdvertisementAdvertisement AdvertisementMeanwhile, in India, several companies obtained early approval for generic replacements and began selling them the day the patents expired. Swiss generic drugmaker Sandoz told Reuters last November that unbranded versions of Ozempic should launch in Canada by the end of June.

Source: National Post March 28, 2026 17:21 UTC